Poliovirus type 1 in working stocks of typed human rhinoviruses

Marc Davies, Christine Bruce, Kevin Bewley, Mark Outlaw, Valerie Mioulet, Graham Lloyd, Christopher Clegg*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)


After eradication of circulating polioviruses, reintroduction might arise from cultured laboratory stocks, or from collections of patients' or environmental samples. In an example of a further class of risk, we recorded poliovirus type 1 in at least four working stocks of what had been identified as various serotypes of human rhinovirus. This finding emphasises the need to urgently assess the possibility of presence of poliovirus, even in apparently well-characterised stocks of other viruses, to screen for the virus where necessary, and to destroy materials in which risk outweighs potential benefit.

Original languageEnglish
Pages (from-to)1187-1188
Number of pages2
JournalThe Lancet
Issue number9364
Publication statusPublished - 5 Apr 2003

Bibliographical note

Funding Information:
We thank David Tyrrell, former Director of the Medical Research Council Common Cold Research Unit, who provided helpful background information. We acknowledge financial support from the Wellcome Trust (grants 056726 and 068686) and the Office of Science and Technology for the NCPV. The funding sources had no role in study design, data collection, data analysis, data interpretation, or writing of the report.


Dive into the research topics of 'Poliovirus type 1 in working stocks of typed human rhinoviruses'. Together they form a unique fingerprint.

Cite this